BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33928568)

  • 1. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
    Catuogno S; Esposito CL; Giangrande PH
    Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
    Gilboa-Geffen A; Hamar P; Le MT; Wheeler LA; Trifonova R; Petrocca F; Wittrup A; Lieberman J
    Mol Cancer Ther; 2015 Oct; 14(10):2279-91. PubMed ID: 26264278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
    Bagalkot V; Gao X
    ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
    Subramanian N; Kanwar JR; Kanwar RK; Krishnakumar S
    Nucleic Acid Ther; 2015 Dec; 25(6):317-22. PubMed ID: 26334953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth.
    Xue L; Maihle NJ; Yu X; Tang SC; Liu HY
    Mol Pharm; 2018 Nov; 15(11):4801-4813. PubMed ID: 30222359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
    Wilner SE; Levy M
    Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.
    Hussain AF; Tur MK; Barth S
    Nucleic Acid Ther; 2013 Jun; 23(3):203-12. PubMed ID: 23544955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
    Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.
    Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S
    Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.